Rashmi Gupta, Wentian Li, Xiao J. Yan, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi and Patricia K. A. Mongini J Immunol May 15, 2019, 202 (10) 2924-2944; DOI: https://doi.org/10.4049/jimmunol.1801142 Key Points TLR9-primed human B-CLL clones respond to IL-15 with AKT and STAT5 activation. PI3K/AKT and STAT5 pathways elevate cyclin D2 and repress ATM, TP53BP1, and MDC1. Inhibitors of PI3K or STAT5 block in vitro B-CLL cycling induced by CpG DNA and IL-15.
Articles by rashmi gupta
Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins | The Journal of Immunology
Rashmi Gupta, Wentian Li, Xiao J. Yan, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi and Patricia K. A. Mongini J Immunol April 15, 2019, ji1801142; DOI: https://doi.org/10.4049/jimmunol.1801142 KEY POINTS TLR9-primed human B-CLL clones respond to IL-15 with AKT and STAT5 activation. PI3K/AKT and STAT5 pathways elevate cyclin D2 and repress ATM, TP53BP1, and MDC1. Inhibitors of PI3K or STAT5 block in vitro B-CLL cycling induced by CpG DNA and IL-15.
Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion
Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion Rashmi Gupta, Xiao J. Yan, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi, Patricia K. A. Mongini The Journal of Immunology September 1, 2018, 201 (5) 1570-1585; DOI: 10.4049/jimmunol.1800591
Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion
Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion Rashmi Gupta, Xiao J. Yan, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi, Patricia K. A. Mongini The Journal of Immunology August 1, 2018, ji1800591; DOI: 10.4049/jimmunol.1800591
Developments in the Polio Vaccine Field: Using cold adaptation to produce safe inactivated vaccine candidates | PLOS ECR Community
Poliomyelitis, or polio, is a debilitating childhood disease caused by poliovirus. It has been eliminated from most parts of the world thanks to the extensive use of polio vaccines. However, there are concerns that current vaccines could lead to the reemergence of poliovirus in a polio-free world. It is important to safeguard this eradication by developing safer and more effective strains of polio for use in future vaccine preparations.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with rashmi
Contact rashmi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack